Events Calendar

Flat View
See by year
Monthly View
See by month
Weekly View
See by week
Daily View
See Today
Categories
See by categories
Search
Search
 

Ontario’s Follow-On Investment Forum, June 18

Tuesday 18 June 2013

Ontario’s Follow-On Investment Forum, June 18
This event is on 18 June 2013 10:00am  

 

Ontario Angels and their leading companies will have an opportunity to engage with the following Venture Capitalists:

    OMERS Ventures
    BDC Venture Capital
    RBC Ventures
    Tandem Expansion
    Inovia
    Rho
    Plazacorp
    Summerhillvp
    Brightspark

 

 Among the confirmed speakers are:

    John Ruffolo, Chief Executive Officer, OMERS Ventures
    Parker MacDonell,  Founding Member, Ohio TechAngel Fund & Board Member-Elect, Angel Capital Association

 

WHO IS THIS EVENT FOR?

    Angel investors (private equity, accredited investors)
    Early-stage private equity & venture capital firms
    Angel-backed Ontario-based companies

 

WHEN: TUESDAY, JUNE 18th, 2013 from 10:00 AM to 6:30 PM with optional dinner roundtables following the event

WHERE: Arcadian Loft, 401 Bay Street, Simpson Tower, 8th Floor, Toronto, ON M5H 2Y4 (Convenient parking near City Hall and walking distance from Union Station)

For more information plase visit NAO Ontario

 

Location :

Arcadian Loft

401 Bay Street, Simpson Tower, 8th Floor, Toronto, ON M5H 2Y4

Toronto, Ontario, M5H 2Y4

Canada

 
 

Back

cb photo 109 5616cbbea0f92

DR. KAY PALMER

Patent Agent


Kay drafts and prosecutes patents in the fields of biochemical, pharmaceutical and molecular biology.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More